|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 243.4 ILa | -1.58% |
|
-5.70% | -18.81% |
| 05-23 | Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M | MT |
| 05-23 | Evogene Ltd. Provides Revenue Guidance for the Year 2024 | CI |
Evogene Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 4.19 million compared to USD 0.641 million a year ago. Net loss was USD 3.86 million compared to USD 6.27 million a year ago.
Basic loss per share from continuing operations was USD 0.08 compared to USD 0.15 a year ago. Diluted loss per share from continuing operations was USD 0.08 compared to USD 0.15 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.81% | 33.69M | |
| +40.80% | 53.67B | |
| +35.79% | 38.86B | |
| -8.05% | 38.76B | |
| -8.98% | 27.27B | |
| +10.69% | 25.91B | |
| -16.21% | 20.29B | |
| +31.00% | 12.78B | |
| +28.51% | 12.18B | |
| -1.67% | 11.96B |
EVOGENE LTD. 